Qualiten Cancer TM

A Peer-Reviewed International Journal

EDITORIAL BOARD HIGHLIGHTS

Leading the Journal and its Peer Review Process

Scholarly publishing is community driven service where subject matter experts (editors and peer-reviewers) play pivotal role in preserving the integrity and standard of scientific output that reaches to the public. Without their consistent support and volunteerism, a fruitful scholarly communication cannot exist.

Currently, Qualiten Cancer is constructing its Editorial Board, which will be composed of subject matter experts from Cancer. We are inviting scientists and physicians conducting research and/or practice in areas such as basic science, translational science, medical devices, drug development, medicine, healthcare, statistics, regulatory affairs, medical law and ethics. The invitation and selection are based on an overall review of professional experience, including research experience, publication record, match of expertise with the scope of journal, manuscript review experience, mentorship record (trained PhDs/MDs/Postdocs), international acclaim and overall contribution to the field.


Editors perform in-depth evaluation and decision making during manuscript peer review process. Once a submitted manuscript has passed the internal quality check (plagiarism check, scientific merit check, ethical compliance and other checks) from journal staff, it is assigned to the suitable Editorial Board member (referred as “handling editor”, who is an expert in the field of article). Thereafter, all the evaluation on quality and decision on acceptance, revision or rejection of article are made solely by handling editor based on the feedback provided by other external peer-reviewers (who are competent peers working in the similar fields).

Editors also evaluate the cases of complex ethical misconduct and disputes (research integrity, data fabrication, data falsification, etc.) and provide their decisions to help the Journal maintain the quality and ethical standards in publishing. To learn more about responsibilities, processes, ethics, and benefits check “Editor Invite”, “Resources for Editors” and “Ethics for Editors”.

Current Editorial Board

Total Editors 3 and Search Result: 0

Hemal Somaiya
Hemal Somaiya
MBS
PharmaForceIQ, Hingham, USA

Key Areas of Expertise:
Oncology, clinical studies, public health, artificial intelligence, machine learning
Profile Summary
    Hemal is the Head of Omnichannel Marketing at PharmaForceIQ, USA leading an innovative unique machine learning platform to ensure the right drugs get to patients. Prior to PharmaForceIQ, she worked as the Global Marketing Senior Director for Merck KGaA, USA and AstraZeneca, USA leading blockbuster drug launches for life threatening diseases.

    She has 15 years of experience in the pharmaceutical industry with extensive experience leading early-stage to launch marketing and life-cycle management initiatives for multiple oncology brands. Most recently, her focus has been on integrating artificial intelligence and machine learning in the pharmaceutical industry.
Reham Abdel-Wahab
Reham Abdel-Wahab
MD, PhD
Assiut University, Assiut, Egypt;
Cholangiocarcinoma Foundation, Salt Lake City, USA

Key Areas of Expertise:
Clinical oncology, gastrointestinal cancer, genomics, patient registry, patient advocacy
Profile Summary
    Dr. Reham Abdel-Wahab has more than 15 years of clinical and research experience in oncology, especially gastrointestinal malignancies. Currently, she is a faculty in Assiut University, as well as performs scientific activities as Director of Research and Chief Scientific Officer at Cholangiocarcinoma Foundation, USA.

    She has postdoctoral and research investigator experience from MD Anderson Cancer Center, USA. Additionally, she has participated in various clinical activities at various institutes in Canada and Denmark. She holds MD and PhD from Assiut University, Egypt.

    Articles: PubMed
Vijayalaxmi Gupta
Vijayalaxmi Gupta
PhD
Washington University School of Medicine, St. Louis, USA

Key Areas of Expertise:
Cancer biology, metastasis, ovarian cancer, reproductive biology, translational science, drug discovery
Profile Summary

PARTICIPATE WITH US

Your participation supports integrity and accessibility in science

Editorial Board membership is primarily invitation based or through a referral from another Editorial Board member. The invitation and selection are based on an overall review of professional experience, including research experience, publication record, match of expertise with the scope of journal, manuscript review experience, mentorship record (trained PhDs/MDs/Postdocs), international acclaim, and overall contribution to the field.

Please check “Editor Invite”, “Resources for Editors” and “Ethics for Editors” to find the qualification, processes and benefits of participating with us. If you have any questions or interested in participating in editorial or reviewing activities, please write to us at editorialoffice@qualitenjournals.com. We look forward to working together.

"Public is the funder, creator and user of research; hence public should get unrestricted access to published research outcomes."

 - Qualiten Press

Get In Touch

Need support or have a question? Live Chat, Call, Text, Fax, Journal Specific E-mail or submit contact form below:

Live Chat

Click to Chat

+1-844-782-5410

Toll Free Call (+1-844-QUALI10)

+1-619-642-5040

Text & Call

+1-833-782-5410

Fax (+1-833-QUALI10)

9:00AM - 5:00PM PST

Hours (Mon-Fri)

2888 Loker Avenue East, Carlsbad, CA 92010, United States of America

Location



Read & Publish with confidence,
you are Secure With Us